CME Group (NASDAQ:CME) Stock Rating Reaffirmed by Rosenblatt Securities

CME Group (NASDAQ:CMEGet Free Report)‘s stock had its “sell” rating restated by analysts at Rosenblatt Securities in a report issued on Thursday, Benzinga reports. They currently have a $187.00 price objective on the financial services provider’s stock, up from their previous price objective of $185.00. Rosenblatt Securities’ price objective would suggest a potential downside of 12.04% from the company’s previous close.

Several other equities analysts also recently commented on the company. Barclays upped their price objective on CME Group from $225.00 to $226.00 and gave the company an “equal weight” rating in a research note on Monday, April 8th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $210.00 price objective (down from $235.00) on shares of CME Group in a research note on Friday, April 5th. Argus raised their price target on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday, March 6th. The Goldman Sachs Group downgraded CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price target on the stock. in a research report on Wednesday, January 3rd. Finally, Morgan Stanley boosted their price target on shares of CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 9th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $216.40.

Read Our Latest Report on CME Group

CME Group Trading Down 1.9 %

CME opened at $212.59 on Thursday. The firm has a market capitalization of $76.53 billion, a PE ratio of 23.97, a P/E/G ratio of 6.09 and a beta of 0.49. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group has a fifty-two week low of $175.73 and a fifty-two week high of $223.80. The company’s 50-day moving average is $214.73 and its 200 day moving average is $211.93.

CME Group (NASDAQ:CMEGet Free Report) last announced its earnings results on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.10. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The company had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter in the previous year, the firm earned $1.92 earnings per share. CME Group’s quarterly revenue was up 19.2% on a year-over-year basis. As a group, research analysts predict that CME Group will post 9.58 earnings per share for the current fiscal year.

Institutional Investors Weigh In On CME Group

Several institutional investors have recently modified their holdings of the business. Gold Investment Management Ltd. bought a new stake in shares of CME Group in the fourth quarter worth approximately $26,000. OFI Invest Asset Management purchased a new stake in CME Group during the 3rd quarter valued at $25,000. Northwest Financial Advisors purchased a new position in shares of CME Group in the 4th quarter worth $28,000. Harbor Investment Advisory LLC grew its holdings in shares of CME Group by 966.7% in the fourth quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 145 shares during the period. Finally, BKM Wealth Management LLC purchased a new stake in CME Group during the fourth quarter valued at $38,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.